Amifampridine phosphate (Firdapse(®)) is effective and safe in a phase 3 clinical trial in LEMS

Oh, Shin J; Shcherbakova, Natalya; Kostera-Pruszczyk, Anna; Alsharabati, Mohammad; Dimachkie, Mazen; Blanco, Jose Munoz; Brannagan, Thomas; Lavrnić, Dragana; Shieh, Perry B; Vial, Christophe; Meisel, Andreas; Komoly, Samuel; Schoser, Benedikt; Sivakumar, Kumaraswamy; So, Yuen

Rezultati

eNauka > Rezultati > Amifampridine phosphate (Firdapse(®)) is effective and safe in a phase 3 clinical trial in LEMS

Naziv:	Amifampridine phosphate (Firdapse(®)) is effective and safe in a phase 3 clinical trial in LEMS
Autori:	Oh, Shin J; Shcherbakova, Natalya; Kostera-Pruszczyk, Anna; Alsharabati, Mohammad; Dimachkie, Mazen; Blanco, Jose Munoz; Brannagan, Thomas; Lavrnić, Dragana ; Shieh, Perry B; Vial, Christophe; Meisel, Andreas; Komoly, Samuel; Schoser, Benedikt; Sivakumar, Kumaraswamy; So, Yuen;
Godina:	2016
Publikacija:	Muscle and Nerve
ISSN:	0148-639X Muscle and Nerve Pretraži identifikator
Tip rezultata:	Naučni članak
Kolacija:	vol. 53 br. 5 str. 717-725
DOI:	10.1002/mus.25070
WoS-ID:	000375116300008
Scopus-ID:	2-s2.0-84959540076
URI:	https://enauka.gov.rs/handle/123456789/421031
Izvor metapodataka:	Migrirano iz RIS podataka
M-kategorija:	22M22 - Rad u istaknutom međ. časopisu

47
SCOPUS^TM

44
OpenCitations

39
WEB OF SCIENCE^TM

Alt metrika

Dimensions

Pronađi DOI

Pronalaženje DOI u servisu CrossRef-u na osnovu meta-podataka u zapisu. Prikazaće se DOI (i metapodaci) čiji se podaci najviše poklapaju. OPREZ - to ne mora biti ta publikacija.

Unpaywall

Rezultati na eNauka su zaštićeni autorskim pravima i sva prava su zadržana, osim ako nije drugačije naznačeno.